Skip to main navigation Skip to search Skip to main content

Oligonucleotide array-in-well platform for detection and genotyping human adenoviruses by utilizing upconverting phosphor label technology

  • Minna Ylihärsilä*
  • , Timo Valta
  • , Maija Karp
  • , Liisa Hattara
  • , Emilia Harju
  • , Jorma Hölsä
  • , Petri Saviranta
  • , Matti Waris
  • , Tero Soukka
  • *Corresponding author for this work

    Research output: Contribution to journalArticleScientificpeer-review

    Abstract

    We have developed a robust array-in-well test platform based on an oligonucleotide array, combining advantages of simple instrumentation and new upconverting phosphor reporter technology. Upconverting inorganic lanthanide phosphors have a unique property of photoluminescence emission at visible wavelengths under near-infrared excitation. No autofluorescence is produced from the sample or support material, enabling a highly sensitive assay. In this study, the assay is performed in standard 96-well microtiter plates, making the technique easily adaptable to high-throughput analysis. The oligonucleotide array-in-well assay is employed to detect a selection of ten common adenovirus genotypes causing human infections. The study provides a demonstration of the advantages and potential of the upconverting phosphor-based reporter technology in multianalyte assays and anti-Stokes photoluminescence detection with an anti-Stokes photoluminescence imaging device.
    Original languageEnglish
    Pages (from-to)1456-1461
    JournalAnalytical Chemistry
    Volume83
    Issue number4
    DOIs
    Publication statusPublished - 2011
    MoE publication typeA1 Journal article-refereed

    Fingerprint

    Dive into the research topics of 'Oligonucleotide array-in-well platform for detection and genotyping human adenoviruses by utilizing upconverting phosphor label technology'. Together they form a unique fingerprint.

    Cite this